01080nam0-22003611i-450-99000794797040332120070130092234.088-88143-17-3000794797FED01000794797(Aleph)000794797FED0100079479720041112d2002----km-y0itay50------baitaITa-------001yyCamillo Boitoun protagonista dell'ottocento italianoa cura di Guido Zucconi e Tiziana SerenaVeneziaIstituto Veneto di Scienze, Lettere ed Artic2002212 p.ill.24 cmRelazioni presentate al Convegno tenuto a Venezia nel 2000Boito, Camillo720.9221itaZucconi,Guido<1950- >Serena,TizianaITUNINARICAUNIMARCBK990007947970403321720.92 ZUC 1Bibl.49936FLFBC17.4375207DARSTFLFBCDARSTCamillo Boito347375UNINA03841nam 22006735 450 991043800900332120251126130424.01-283-61267-497866139251213-7091-0912-410.1007/978-3-7091-0912-0(CKB)2670000000250250(EBL)973903(OCoLC)808123434(SSID)ssj0000733412(PQKBManifestationID)11400450(PQKBTitleCode)TC0000733412(PQKBWorkID)10715348(PQKB)11177970(DE-He213)978-3-7091-0912-0(MiAaPQ)EBC973903(PPN)168331144(EXLCZ)99267000000025025020120817d2013 u| 0engur|n|---|||||txtccrDrug Therapy for the Elderly /edited by Martin Wehling1st ed. 2013.Vienna :Springer Vienna :Imprint: Springer,2013.1 online resource (355 p.)Description based upon print version of record.3-7091-0911-6 Includes bibliographical references and index.Foreword -- Part 1: General aspects -- Part 2: Special considerations with regard to organ systems based on geriatric clinical importance -- Part 3: Pharmacotherapy and geriatric syndromes -- Part 4: Further problem areas in gerontopharmacotherapy and pragmatic recommendations.With people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As aging people often suffer from several chronic diseases and are being treated with multiple medications concurrently, unwanted drug interactions occur more frequently. Whereas recent approaches have recommended to remove particular drugs from the medication regimen to avoid adverse effects, Drug Therapy for the Elderly underlines both indispensable and dispensable elements of drug treatment, providing the practitioner with: - Background information on the elderly population regarding their needs for particular drugs (with an eye to frailty, co-morbidity patterns, and special sensitivities regarding drug metabolism and excretion) - Practical advice about drug treatment surveillance parameters in the elderly - In-depth discussion of drugs in relation to the elderly with specific diagnoses - Integration of multimorbidity/polypharmacy situations into prioritization schemes - A plan for how to deal with the complexity of polypharmacy situations in a five-minute consultation An original classification of drugs is proposed by the editor which relates the power of effects, prognostic data, and tolerability to a prioritization scoring system. This approach is the first to not only provide a negative listing, but also integrates positive data into an overall assessment for drugs fit for the aged. Therefore, Drug Therapy for the Elderly serves as a timely reference for a wide array of physicians.GeriatricsInternal medicinePharmacologyGeriatricsInternal MedicinePharmacologyGeriatrics.Internal medicine.Pharmacology.Geriatrics.Internal Medicine.Pharmacology.615.7042Wehling Martin1750245MiAaPQMiAaPQMiAaPQBOOK9910438009003321Drug therapy for the elderly4184836UNINA